Navigation Links
EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
Date:1/23/2008

Multi-Center Clinical Trial to be Conducted in Canada

ROCKVILLE, Md., Jan. 23 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the commencement of a Phase 2 study with its novel cell cycle inhibitor, MKC-1, in recurrent or resistant epithelial ovarian cancer and advanced endometrial cancer patients. The study will be conducted at multiple sites in Canada with Dr. Amit Oza, Senior Staff Physician and Associate Professor of Medicine, Princess Margaret Hospital, University of Toronto, serving as the principal investigator.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

The primary objective of this Phase 2 study will be to determine the antitumor activity of MKC-1 administered orally as a single agent in platinum or taxane refractory ovarian and endometrial cancer patients. In addition, safety, response duration in patients with an objective response, and progression free survival (PFS) will also be assessed. The study will be a two arm parallel group design with each group having two stages.

MKC-1 is a novel, orally-active cell cycle inhibitor with in vitro and in vivo efficacy against a broad range of human solid tumor cell lines, including multi-drug resistant cell lines. Data from previous studies with MKC-1 demonstrate broad-acting antitumor effects, showing tumor growth inhibition or regression in multiple preclinical models, including paclitaxel-resistant models.

MKC-1 has been shown to inhibit mitotic spindle formation, prevent chromosome segregation in th
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
8. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
9. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
10. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
11. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....25/PRNewswire/-- FromNovember16-18,Phonak,thelead...tedthesecondeditionoftheHearingCareforAdultsConfer....Theconferencebroughttogetherleadingexpertsinaging...ianswhoworkeverydaywitholderpeoplewithhearinglossf...stresearchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...swire-FirstCall/--Formanyofthemillionsofhearingimp...reated hearingloss ,theholidaysmaynotbeallthathapp...vicepresidentofHearUSA(Amex: EAR ),oneofAmerica,sl...dieshavelinkedhearinglosstostress,frustration,ands...aygatheringswithfamiliesandfriends,whenmanyofthose...
(Date:11/25/2009)...wire/--RegadoBiosciences,aprivatelyheldcompanylead...econtrolagents,announcedthatDavidMazzo,PhD,CEOandP...alHealthCareConferenceattheNewYorkPalaceHotelinNew...(EST)onTuesday,December1andwillincludeanoverviewof...ntprogram,theanticoagulantsystem,REG1.Thehealthcar...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Wound Management Technologies Inc Announces Conference Plans and Presentations on Advanced Wound Care Product 50900 1Wound Management Technologies Inc Announces Conference Plans and Presentations on Advanced Wound Care Product 50900 2Wound Management Technologies Inc Announces Conference Plans and Presentations on Advanced Wound Care Product 50900 3Premier Research Launches Oracle 28R 29 Remote Data Capture Onsite 4 5 3 50898 1Premier Research Launches Oracle 28R 29 Remote Data Capture Onsite 4 5 3 50898 2VisEn Launches New Cat K FAST 28TM 29 Fluorescence Molecular Imaging Agent 12916 1VisEn Launches New Cat K FAST 28TM 29 Fluorescence Molecular Imaging Agent 12916 2
...ELPHIA, Oct. 26 Children with Down,syndrome are m...higher,levels of a hormone associated with obesity... leptin, may contribute to the known higher risk,o...rome., A research team from The Children,s Hospit...nia School of Medicine published their study onlin...
..., Calif., Oct. 26 IDM Pharma, Inc.,(Nasdaq: IDMI...ment of,innovative cancer therapies, today announc...ng three of the Company,s pipeline compounds to be...ic presentation details are as follows:, Mifamurt...ty (CTOS) -- Seattle, Wash. Oral presentation -- ...
Other Medicine Technology:Obesity-Related Hormone is Higher in Children with Down Syndrome 2IDM Pharma Announces Upcoming Clinical Data Presentations 2IDM Pharma Announces Upcoming Clinical Data Presentations 3IDM Pharma Announces Upcoming Clinical Data Presentations 4
(Date:11/25/2009)...w definite conclusions, experts say, , ,...ic patients with blocked coronary arteries, there ...r whether patients undergo bypass surgery or angio..., Bypass surgery has been the standard treatmen...se. However, less invasive approaches such as angi...
(Date:11/25/2009)...erlook needed care, study finds , , WEDN...ession can worsen her child,s asthma, U.S. researc... black mothers and their children found that child... more frequent asthma symptoms, while children of ...equent asthma symptoms. , The Johns Hopkins Chi...
(Date:11/25/2009)...ncare ®isproudtosupportGNC,seffortstoraisemor...e ThanksandGiving campaign,$1fromthepurchasepriceo...willbedonatedtoSt.Jude.Additionally,GNCcustomersha...tatoneoftheir5,000+retaillocationsoratGNC.com.GNCh...009 ThanksandGiving campaign. ,, "Wearedelighte...
(Date:11/25/2009)...into the body on a carefully engineered, fingernai...nate tumors in mammals, scientists report this wee... , The new approach, pioneered by bioengineers a...ic disks impregnated with tumor-specific antigens ...alian immune system to attack tumors. The new pape...
(Date:11/25/2009)... cells, study finds , , WEDNESDAY, Nov. ...in a fingernail-size implant eliminated melanoma t...d uses polymer disks, 8.5 millimeters in diameter,...implanted under the skin to reprogram the immune s...entists who developed the implant predicted that i...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... a bigger trial of a vaccine against the most comm...ntially increased survival time for many. // ...involving 171 patients who had responded to conven...ews. The vaccine was developed following res...
...nd patients about commonly used thyroid medication...of the drugs, a senior endocrinologist has warned....onash University and The Alfred and Epworth Hospit...ods Administration (TGA). Prof Stockigt fou...
...mmel Cancer Center at Thomas Jefferson University ...elphia, shows that pancreatic cancer patients //65...ry have nearly as good a chance as anyone else to ...my, or Whipple procedure, which entails the remova...
... states will make space for a new entrant, The Foo...ple to buy the right kind of food. //The novel rai...s the federal dietary guidelines is one of the str...as begun going places. The guide, shaped like a tr...
...t to Heart Attack: Michael Lim, M.D., assistant pr...sity School of Medicine, says it’s crucial to be o...ion called cardiogenic shock, which affects one in...ity of the heart that cannot adequately supply the...
...at anger and hostility, in and of themselves, can ...he research has included women. // Results o...ubjects, suggest that anger and hostility alone ar... other risk factors: age (risk increases as women ...
Other Medicine News:Health News:Medicine Information Out of Date 2Health News:Study: Older Pancreatic Cancer Surgery Survivors Live Long 2Health News:Outwardly Expressed Anger Affects Some Women’s Heart Arterie 2
Basic modular VICTOR2 Multilabel Counter (3 technologies)
VICTOR2 V (5 technologies), manual model
VICTOR2 multilabel counter with stacker and robot loading
... 96-channel parallel detection of fluorescence, ab...l microtiter plates. Compact workstations and sys...ansport of microtiter plates with a throughput of ... switching required by numerous other systems to s...
Medicine Products: